Pyxis Oncology, Inc.
PYXS
$1.04
-$0.005-0.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 126.93M | 144.82M | 155.72M | 157.03M | 119.30M |
| Total Receivables | -- | -- | -- | 8.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 761.00K | 2.58M | 3.84M | 5.88M | 1.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.75M | 1.47M | 1.47M | 1.47M | 4.29M |
| Total Current Assets | 132.44M | 148.87M | 161.04M | 172.38M | 124.60M |
|
|
|||||
| Total Current Assets | 132.44M | 148.87M | 161.04M | 172.38M | 124.60M |
| Net Property, Plant & Equipment | 22.14M | 22.82M | 23.68M | 24.11M | 24.81M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.60M | 23.62M | 23.68M | 23.73M | 24.31M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 157.18M | 195.31M | 208.39M | 220.22M | 173.73M |
|
|
|||||
| Total Accounts Payable | 4.86M | 4.87M | 5.47M | 2.29M | 3.90M |
| Total Accrued Expenses | 10.73M | 14.06M | 10.09M | 10.83M | 12.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.45M | 1.39M | 1.34M | 1.02M | 1.23M |
| Total Finance Division Other Current Liabilities | 643.00K | -- | -- | -- | 8.02M |
| Total Other Current Liabilities | 643.00K | -- | -- | -- | 8.02M |
| Total Current Liabilities | 17.68M | 20.32M | 16.90M | 14.14M | 25.76M |
|
|
|||||
| Total Current Liabilities | 17.68M | 20.32M | 16.90M | 14.14M | 25.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.75M | 19.15M | 19.53M | 19.76M | 20.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 2.16M | 2.16M | 2.16M | 2.16M |
| Total Liabilities | 36.43M | 41.63M | 38.60M | 36.06M | 48.02M |
|
|
|||||
| Common Stock & APIC | 484.14M | 481.31M | 476.68M | 473.70M | 411.87M |
| Retained Earnings | -363.56M | -327.99M | -306.78M | -289.48M | -286.23M |
| Treasury Stock & Other | 170.00K | 351.00K | -102.00K | -60.00K | 63.00K |
| Total Common Equity | 120.75M | 153.68M | 169.79M | 184.16M | 125.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 120.75M | 153.68M | 169.79M | 184.16M | 125.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 120.75M | 153.68M | 169.79M | 184.16M | 125.70M |
|
|
|||||